ARTEMIS NEURO EVACUATION DEVICE AP28

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2017-11-14 for ARTEMIS NEURO EVACUATION DEVICE AP28 manufactured by Penumbra, Inc..

Event Text Entries

[93079122] Results: upon first evaluation, significant clot burden was observed inside the artemis neuro evacuation device (artemis) hypotube. The location of the distal end of the wire was within specification. During functional analysis, the artemis was connected with a demonstration pump max. Upon depressing the artemis button, the wire rotated as intended. The pump max was powered on, and the observed vacuum level was less than -25inhg. Water was aspirated through the artemis, and significant clot burden was removed from the hypotube. Upon removing the clot burden from the hypotube, the vacuum level returned to -25inhg, and the artemis functioned as intended. Following functional analysis, the artemis was opened by penumbra engineers and there was no visible damage to the artemis. Conclusions: evaluation of the returned device revealed that significant clot burden was partially occluding the hypotube. The observed partial occlusion reduced the vacuum level through the artemis. When the occlusion was cleared by aspirating water through the artemis, the vacuum level returned to -25inhg. Partial occlusion of the hypotube likely contributed to the reported issues with not performing to maximum aspiration. The critical dimensions of the artemis were within specification, and the device functioned as intended. Penumbra artemis devices are visually and functionally inspected during incoming quality inspection. The testing and inspection records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
Patient Sequence No: 1, Text Type: N, H10


[93079123] The patient was undergoing microneurosurgery procedure to treat a basal ganglia hematoma using the artemis neuro evacuation device (artemis). During the procedure, while using the artemis with a penumbra system aspiration pump max 110v (pump max), the physician noticed that the artemis seemed to be "underpowered" and not performing to its max aspiration. Therefore, the artemis was removed and a new artemis was opened but the physician indicated that the new artemis felt the same as the first one. Although the second artemis seemed to be "underpowered", the physician successfully completed the procedure using the second artemis and the same pump max. It is unclear if the artemis was in fact "underpowered" or if the clot was just tenacious and not able to be evacuated. It should be noted that there was no reported issue with the pump max. Additionally, there was no report of an adverse effect to the patient.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005168196-2017-01964
MDR Report Key7031423
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2017-11-14
Date of Report2017-10-15
Date of Event2017-10-15
Date Mfgr Received2017-10-15
Device Manufacturer Date2017-08-14
Date Added to Maude2017-11-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. VERONICA FARRIS
Manufacturer StreetONE PENUMBRA PLACE
Manufacturer CityALAMEDA CA 94502
Manufacturer CountryUS
Manufacturer Postal94502
Manufacturer Phone5107483200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARTEMIS NEURO EVACUATION DEVICE
Generic NameGWG
Product CodeGWG
Date Received2017-11-14
Returned To Mfg2017-10-18
Catalog NumberAP28
Lot NumberS10002
ID NumberNI
OperatorPHYSICIAN
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerPENUMBRA, INC.
Manufacturer AddressONE PENUMBRA PLACE ALAMEDA CA 94502 US 94502


Patients

Patient NumberTreatmentOutcomeDate
10 2017-11-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.